• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

PetDx names new president and chief executive officer

January 25, 2023
dvm360 Staff

Alejandro Bernal, DVM, MS, MBA, will succeed PetDx founder Daniel S. Grosu, MD, MBA

PetDx announced it has appointed Alejandro Bernal, DVM, MS, MBA, as its new president and chief executive officer. Bernal succeeds PetDx founder Daniel S. Grous, MD, MBA, who will continue to serve as Chairman of the Board.

"Alejandro Bernal is one of the most respected leaders in the animal health industry, with extensive experience in driving transformative investment agendas and building unique, differentiated, and fast-growing businesses," said Grosue, in an organizational release.1 "We are excited that he brings that experience and passion to PetDx and to OncoK9, the first and only genomics-based multi-cancer early detection test in veterinary medicine."

Bernal received his master of business administration and doctor of veterinary medicine degree from Universidad de los Andes, Colombia, and a master of sciences from Texas A&M. According to the release, Bernal served as president for Mars Veterinary Health International and Global Diagnostics where he led the consolidation and operations of Mars-owned veterinary hospitals outside of North America, plus Antech’s network of veterinary reference labs. Before working for Mars, Bernal worked 17 years with Zoetis serving as a member of the executive team that worked in global leadership and strategy roles.

"I have always been passionate about the role that innovation and new technologies can play in improving the lives of pets. Over the past decade, rapidly evolving next-generation sequencing-based testing solutions have revolutionized multiple specialty areas in human medicine, improving the quality of care for millions of people,” expressed Bernal.1

Advertisement

“Genomic medicine is now making rapid inroads into veterinary care and holds particular promise for the detection, characterization, and management of cancer, which is by far the biggest cause of death in dogs. The cutting-edge liquid biopsy solutions developed by PetDx are without parallel in veterinary diagnostics, and I am excited to join such an innovative company at this unique point in their growth trajectory," he concluded.1

Reference

PetDx Appoints Alejandro Bernal as its New President and Chief Executive Officer. News release. PetDx. January 24, 2023. Accessed January 25, 2023. https://prnmedia.prnewswire.com/news-releases/petdx-appoints-alejandro-bernal-as-its-new-president-and-chief-executive-officer-301729681.html

Related Content:

Business
The Vets appoints Dr Zach Mills to VP of Medical Performance
The Vets appoints Dr Zach Mills to VP of Medical Performance
Purina announces its 2023 Pet Care Innovation Prize winners
Purina announces its 2023 Pet Care Innovation Prize winners
AmeriVet Veterinary Partners deemed a 2022 Business of the Year
AmeriVet Veterinary Partners deemed a 2022 Business of the Year

Advertisement

Latest News

The Vets appoints Dr Zach Mills to VP of Medical Performance

Communicating the importance of genetic screening

Purina announces its 2023 Pet Care Innovation Prize winners

AmeriVet Veterinary Partners deemed a 2022 Business of the Year

View More Latest News
Advertisement